Miles Wang：https://mileskwang.com/，是一名OpenAI研究员，他的工作包括利用人工智能加速科学和生物学发现。据四位知情人士透露，他将离开ChatGPT制造商，创办一家新的初创公司，专注于开发用于药物发现的人工智能模型。预计还有其他几位OpenAI研究员会加入这家公司。
两位知情人士表示，Wang正在洽谈以20亿美元估值筹集约2亿美元资金。据消息人士称，Lightspeed正讨论主导本轮融资。谈判仍在进行中，交易可能尚未最终确定，具体细节可能会发生变化。
Wang对报道中的融资数字和公司描述提出异议，但没有具体说明正确的数字或细节。Lightspeed未回应置评请求。
这些融资讨论显示出投资者对应用人工智能在生命科学中取得突破的兴趣。两年前成立的初创公司Chai Discovery，开发能够预测分子相互作用以发现新药的人工智能模型，于周二宣布筹集4亿美元：https://www.nytimes.com/2026/07/14/business/dealbook/chai-discovery-ai-drug-development.html，公司估值为38亿美元。（联合创始人Josh Meier也曾在OpenAI担任研究员。）与此同时，谷歌DeepMind的衍生公司Isomorphic Labs，也在开发用于药物发现的人工智能模型，并于5月完成了21亿美元的B轮融资：https://www.isomorphiclabs.com/articles/isomorphic-labs-announces-series-b-investment-round。
据几位消息人士告诉TechCrunch，Wang的新创公司可能正在开发人工智能模型，以帮助发现现有药物的新用途，甚至可能包括那些先前在试验中失败的药物。为FDA批准的药物寻找新用途可能比从零开始开发新药获得收入的时间显著缩短，因为这些药物已经经过安全性测试。
Wang在从哈佛退学后，于2024年加入OpenAI，当时他正在攻读计算机科学学士学位。（近年来，投资者再次愿意对没有完成大学学业的年轻创始人进行投资：https://techcrunch.com/2025/12/31/college-dropout-has-become-the-most-coveted-startup-founder-credential/。）
在 OpenAI，他共同撰写了研究论文，包括评估 AI 模型如何自动化并加速：https://openai.com/index/accelerating-biological-research-in-the-wet-lab/ 科学发现。
当您通过我们文章中的链接购买时，我们可能会赚取少量佣金：https://techcrunch.com/techcrunch-affiliate-monetization-standards/。这不会影响我们的编辑独立性。
Marina Temkin 是 TechCrunch 的风险投资和初创公司记者。在加入 TechCrunch 之前，她为 PitchBook 和 Venture Capital Journal 撰写风险投资相关内容。在职业早期，Marina 曾是一名金融分析师，并获得 CFA 特许资格。
您可以通过发送电子邮件至 marina.temkin@techcrunch.com：mailto:marina.temkin@techcrunch.com 或通过 Signal 在 1 347-683-3909 上发送加密消息来联系或验证 Marina 的外联。
最后机会，在 TechCrunch 创始人峰会上节省最高 $190。加入 1,000 名各阶段的创始人和风险投资者，获取实用的扩展经验和推动发展的联系。优惠截止时间为 6 月 26 日晚上 11:59（太平洋时间）。
Satya Nadella 向使用 AI 的公司发出了令人震惊的警告：https://techcrunch.com/2026/07/13/satya-nadella-has-issued-a-shocking-warning-to-companies-using-ai/ Julie Bort：https://techcrunch.com/author/julie-bort/
苹果针对 OpenAI 的商业机密诉讼中最疯狂的指控：https://techcrunch.com/2026/07/13/the-wildest-allegations-in-apples-trade-secrets-lawsuit-against-openai/ Sarah Perez：https://techcrunch.com/author/sarah-perez/
Anthropic 开始为印度本地化 Claude 定价，印度是其继美国后的最大市场：https://techcrunch.com/2026/07/13/anthropic-starts-localizing-claude-pricing-for-india-its-biggest-market-after-the-us/ Jagmeet Singh：https://techcrunch.com/author/jagmeet-singh/
Meta 在争议后移除了 Instagram 上的 AI 功能：https://techcrunch.com/2026/07/10/meta-removes-controversial-ai-feature-on-instagram-after-backlash/ Lucas Ropek：https://techcrunch.com/author/lucas-ropek/
苹果以涉嫌商业机密窃取起诉 OpenAI：https://techcrunch.com/2026/07/10/apple-sues-openai-over-alleged-trade-secret-theft/ Sarah Perez：https://techcrunch.com/author/sarah-perez/
埃隆·马斯克称赞 Mythos/Fable，承诺不会‘切断’ Anthropic：https://techcrunch.com/2026/07/09/elon-musk-praises-mythos-fable-promises-not-to-cut-off-anthropic/ 朱莉·博特：https://techcrunch.com/author/julie-bort/
Instagram 用户：以下是如何阻止 Meta 的 AI 使用你的照片：https://techcrunch.com/2026/07/09/how-to-stop-metas-ai-image-generator-from-using-your-instagram-photos/ 劳伦·福里斯塔尔：https://techcrunch.com/author/lauren-forristal/
Miles Wang：https://mileskwang.com/, an OpenAI researcher whose work includes using AI to accelerate scientific and biological discovery, is leaving the ChatGPT maker to launch a new startup focused on developing AI models for drug discovery, according to four people with knowledge of his plans. Several other OpenAI researchers are expected to join the new company.
Wang is in talks to raise about $200 million at a $2 billion valuation, two of the people said. Lightspeed is in discussions to lead the funding round, according to sources. Talks are ongoing, the deal may not be final and details could change.
Wang disputed the story’s funding figures and description of the company but did not specify the correct numbers or details. Lightspeed didn’t respond to a request for comment.
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences. Chai Discovery, a two-year-old startup developing AI models that can predict molecular interactions to identify new drugs, announced on Tuesday that it raised $400 million：https://www.nytimes.com/2026/07/14/business/dealbook/chai-discovery-ai-drug-development.html at a $3.8 billion valuation. (Co-founder Josh Meier also passed through OpenAI as a researcher.) Meanwhile, Google DeepMind spinout Isomorphic Labs, which also develops AI models for drug discovery, raised a $2.1 billion：https://www.isomorphiclabs.com/articles/isomorphic-labs-announces-series-b-investment-round Series B in May.
Wang’s new startup may be working on AI models that will help find new uses for existing drugs and possibly those that previously failed in trials, a couple of sources told TechCrunch. Finding new uses for FDA-approved drugs can result in significantly faster time to revenue than developing new drugs from scratch, as these medicines have already been tested for safety.
Wang joined OpenAI in 2024 after dropping out from Harvard, where he was working on a bachelor’s degree in computer science. (In recent years, investors are once again comfortable betting on young founders who haven’t completed college：https://techcrunch.com/2025/12/31/college-dropout-has-become-the-most-coveted-startup-founder-credential/.)
At OpenAI, he co-authored research papers, including evaluating how AI models can automate and accelerate：https://openai.com/index/accelerating-biological-research-in-the-wet-lab/ scientific discovery.
When you purchase through links in our articles, we may earn a small commission：https://techcrunch.com/techcrunch-affiliate-monetization-standards/. This doesn’t affect our editorial independence.
Marina Temkin is a venture capital and startups reporter at TechCrunch. Prior to joining TechCrunch, she wrote about VC for PitchBook and Venture Capital Journal. Earlier in her career, Marina was a financial analyst and earned a CFA charterholder designation.
You can contact or verify outreach from Marina by emailing marina.temkin@techcrunch.com：mailto:marina.temkin@techcrunch.com or via encrypted message at +1 347-683-3909 on Signal.
Last chance to save up to $190 on TechCrunch Founder Summit. Join 1,000+ founders and VCs at all stages for real-world scaling insights and connections that move the needle. Savings end June 26, 11:59 p.m. PT .
Satya Nadella has issued a shocking warning to companies using AI：https://techcrunch.com/2026/07/13/satya-nadella-has-issued-a-shocking-warning-to-companies-using-ai/ Julie Bort：https://techcrunch.com/author/julie-bort/
The wildest allegations in Apple’s trade secrets lawsuit against OpenAI：https://techcrunch.com/2026/07/13/the-wildest-allegations-in-apples-trade-secrets-lawsuit-against-openai/ Sarah Perez：https://techcrunch.com/author/sarah-perez/
Anthropic starts localizing Claude pricing for India, its biggest market after the US：https://techcrunch.com/2026/07/13/anthropic-starts-localizing-claude-pricing-for-india-its-biggest-market-after-the-us/ Jagmeet Singh：https://techcrunch.com/author/jagmeet-singh/
Meta removes controversial AI feature on Instagram after backlash：https://techcrunch.com/2026/07/10/meta-removes-controversial-ai-feature-on-instagram-after-backlash/ Lucas Ropek：https://techcrunch.com/author/lucas-ropek/
Apple sues OpenAI over alleged trade secret theft：https://techcrunch.com/2026/07/10/apple-sues-openai-over-alleged-trade-secret-theft/ Sarah Perez：https://techcrunch.com/author/sarah-perez/
Elon Musk praises Mythos/Fable, promises not to ‘cut off’ Anthropic：https://techcrunch.com/2026/07/09/elon-musk-praises-mythos-fable-promises-not-to-cut-off-anthropic/ Julie Bort：https://techcrunch.com/author/julie-bort/
Instagram users: Here’s how to stop Meta’s AI from using your photos：https://techcrunch.com/2026/07/09/how-to-stop-metas-ai-image-generator-from-using-your-instagram-photos/ Lauren Forristal：https://techcrunch.com/author/lauren-forristal/
扫码直达文章详情